Safety and Efficacy of Limited Laboratory Monitoring for Hepatitis C Treatment: A Blinded Clinical Trial in Rwanda

Safety and Efficacy of Limited Laboratory Monitoring for Hepatitis C Treatment: A Blinded Clinical Trial in Rwanda

Direct‐acting antivirals for hepatitis C virus (HCV) are highly effective and well‐tolerated. However, only a small percentage of HCV‐infected individuals globally have received therapy. Reducing the complexity of monitoring during HCV therapy, if shown to be safe, could facilitate greater access to...

Full description

Bibliographic Details
Main Authors: Philip Grant, Fabienne Shumbusho, Jennifer Ilo Van Nuil, Fredrick Kateera, Joia Mukherjee, Jules Kabahizi, Fabien Ntaganda, Sabin Nsanzimana, Aimable Mbituyumuremyi, Makuza Jean Damascene, Claude Mambo Muvunyi, Constance Mukabatsinda, Emmanuel Musabeyezu, Cyprien Ntirenganya, Neil Gupta
Format: Article
Language:English
Published: Wolters Kluwer Health/LWW 2020-04-01
Series:Hepatology Communications
Online Access:https://doi.org/10.1002/hep4.1482

Internet

https://doi.org/10.1002/hep4.1482

Similar Items